Abstract:Background: The mTOR complex 1 (mTORC1) phosphorylates ribosomal S6 kinase (S6K1) on Thr-389, leading to S6K1 activation. Results: Inhibition of SIRT1/2, members of the sirtuin family of proteins, induces S6K1 acetylation and inhibits mTORC1-dependent S6K1 phosphorylation. Conclusion: The SIRT1/2 support mTORC1-induced S6K1 activation by inhibiting S6K1 acetylation. Significance: The study provides a novel mechanistic insight into the cross-talk between sirtuins and mTORC1 signaling.p70 ribosomal S6 kinase (S6K1), a major substrate of the mammalian target of rapamycin (mTOR) kinase, regulates diverse cellular processes including protein synthesis, cell growth, and survival. Although it is well known that the activity of S6K1 is tightly coupled to its phosphorylation status, the regulation of S6K1 activity by other post-translational modifications such as acetylation has not been well understood. Here we show that the acetylation of the C-terminal region (CTR) of S6K1 blocks mTORC1-dependent Thr-389 phosphorylation, an essential phosphorylation site for S6K1 activity. The acetylation of the CTR of S6K1 is inhibited by the class III histone deacetylases, SIRT1 and SIRT2. An S6K1 mutant lacking acetylation sites in its CTR shows enhanced Thr-389 phosphorylation and kinase activity, whereas the acetylation-mimetic S6K1 mutant exhibits decreased Thr-389 phosphorylation and kinase activity. Interestingly, relative to the acetylation-mimetic S6K1 mutant, the acetylation-defective mutant displays higher affinity toward Raptor, an essential scaffolding component of mTORC1 that recruits mTORC1 substrates. These observations indicate that sirtuin-mediated regulation of S6K1 acetylation is an additional important regulatory modification that impinges on the mechanisms underlying mTORC1-dependent S6K1 activation.

Sirtuin1 (sirt1) in the Acetylation of Downstream Target Proteins

Cross-talk between Sirtuin and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in the Regulation of S6 Kinase 1 (S6K1) Phosphorylation

Regulation of Glycolytic Enzyme Phosphoglycerate Mutase-1 by Sirt1 Protein-Mediated Deacetylation.

A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.

Inhibitory protein–protein interactions of the SIRT1 deacetylase are choreographed by post‐translational modification

Regulation of SIRT1 and Its Roles in Inflammation

How does acetylation regulate autophagy?

SIRT1 and p53, effect on cancer, senescence and beyond.

Multifaceted regulation of sirtuin 2 (Sirt2) deacetylase activity

Activation and inhibition of sirtuins: From bench to bedside

Sirtuin-1 Regulates Acinar-to-ductal Metaplasia and Supports Cancer Cell Viability in Pancreatic Cancer.

Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation

The NAD+-dependent Protein Deacetylase Activity of SIRT1 is Regulated by Its Oligomeric Status

Sirt1-PPARS Cross-Talk in Complex Metabolic Diseases and Inherited Disorders of the One Carbon Metabolism

Inhibition of Nucleolar Stress Response by Sirt1: A Potential Mechanism of Acetylation-Independent Regulation of P53 Accumulation.

SIRT1 Activation by Natural Phytochemicals: An Overview

SIRT1 Deacetylation and Repression of p300 Involves Lysine Residues 1020/1024 within the Cell Cycle Regulatory Domain 1

Multifaceted Modulation of SIRT1 in Cancer and Inflammation.

A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy

Targeting Sirtuins for Cancer Therapy: Epigenetics Modifications and Beyond

Sirt1 is A Redox-Sensitive Deacetylase That is Post-Translationally Modified by Oxidants and Carbonyl Stress